From: Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively?
 | patients | ||||
---|---|---|---|---|---|
 | Optimal Cytoreduction | Suboptimal Cytoreduction |  | ||
Predictor | No. | percent | No. | percent | P |
Clinical status | Â | Â | Â | Â | Â |
1 | 12 | 44.4 | 15 | 55.6 | 1.91 |
2 | 3 | 23.1 | 10 | 76.9 | Â |
Pleural effusion | Â | Â | Â | Â | Â |
Positive | 1 | 14.3 | 6 | 85.7 | .179 |
Negative | 14 | 41.2 | 20 | 58.8 | Â |
Peritoneal carcinomatosis | Â | Â | Â | Â | Â |
Positive | 3 | 15.8 | 16 | 84.2 | .01 |
Negative | 12 | 54.5 | 10 | 45.5 | Â |
Omental extension | Â | Â | Â | Â | Â |
Positive | 3 | 50 | 3 | 50 | .460 |
Negative | 12 | 34.3 | 23 | 65.7 | Â |
Liver involvement | Â | Â | Â | Â | Â |
Positive | 2 | 40 | 3 | 60 | .866 |
Negative | 13 | 36.1 | 23 | 63.9 | Â |
Peritoneal involvement | Â | Â | Â | Â | Â |
Positive | 5 | 41.7 | 7 | 58.3 | .664 |
Negative | 10 | 34.5 | 19 | 65.5 | Â |
Adenopathy | Â | Â | Â | Â | Â |
Positive | 0 | 0 | 0 | 0 | Â |
Negative | 15 | 36.6 | 26 | 63.4 | Â |
CA-125 | Â | Â | Â | Â | Â |
≤ 400 | 4 | 36.4 | 7 | 63.6 | .911 |
>400 | 10 | 34.5 | 19 | 65.5 | Â |
Ascitis | Â | Â | Â | Â | Â |
≤ 1000 | 10 | 45.5 | 12 | 54.5 | .205 |
>1000 | 5 | 26.3 | 14 | 73.7 | Â |